JP Morgan analyst Kenneth Worthington maintains Moelis (NYSE:MC) with a Neutral and raises the price target from $50 to $51.
Save time and jump to the most important pieces.
| Date | Price Target | Rating | Analyst |
|---|---|---|---|
| 9/12/2024 | $70.00 | Equal Weight | Wells Fargo |
| 3/13/2024 | $53.00 → $58.00 | Sell → Neutral | Goldman |
| 1/29/2024 | $56.00 | Mkt Perform | Keefe Bruyette |
| 1/11/2023 | $40.00 → $37.00 | Neutral → Sell | Goldman |
| 11/3/2022 | $40.00 → $37.00 | Mkt Perform → Underperform | Keefe Bruyette |
| 9/23/2022 | $43.00 → $35.00 | Neutral → Sell | UBS |
| 7/18/2022 | $53.00 → $36.00 | Equal-Weight → Underweight | Morgan Stanley |
| 7/11/2022 | $42.00 | Peer Perform → Underperform | Wolfe Research |
Third quarter GAAP revenues of $273.8 million; Adjusted revenues of $280.7 million, up 1% from the prior year period GAAP revenues for the first nine months of 2024 were $755.8 million; Adjusted revenues of $762.8 million, up 18% from the prior year period GAAP net income of $0.22 per share (diluted) for the third quarter and $0.61 per share (diluted) for the first nine months of 2024; Adjusted net income of $0.22 per share (diluted) for the third quarter and $0.63 per share (diluted) for the first nine months of 2024 Continued to execute on our growth strategy: Year-to-date, promoted seven advisory professionals to Managing Director and hired eight Managing Directors, including on
Moelis & Company (NYSE:MC), a leading global independent investment bank, will release its third quarter 2024 financial results after the market closes on Wednesday, October 23rd, 2024. Ken Moelis, Chairman and Chief Executive Officer, and Joe Simon, Chief Financial Officer, will also host a related conference call at 5:00pm ET on the same day (October 23, 2024) to review the financial results. Following the review, there will be a question and answer session. Investors and analysts may participate in the live conference call by dialing +1 (888) 300 4150 (domestic) or +1 (646) 970 1530 (international) and using access code 8014191. Please dial in 15 minutes before the conference call begi
Moelis (NYSE:MC), a leading global independent investment bank, today announced the appointment of Dr. Louise Mirrer to its Board of Directors, effective September 17, 2024. Dr. Mirrer brings over four decades of experience in academia and the non-profit sector, including more than 20 years of executive leadership. Since 2004, she has been leading the mission and operations of the New York Historical Society as its President and CEO. Under her leadership, Dr. Mirrer has significantly enhanced the New York Historical Society's position as a leading cultural and educational institution. She oversaw the organization's $100 million capital campaign, increased the institution's annual visitorsh
Third quarter GAAP revenues of $273.8 million; Adjusted revenues of $280.7 million, up 1% from the prior year period GAAP revenues for the first nine months of 2024 were $755.8 million; Adjusted revenues of $762.8 million, up 18% from the prior year period GAAP net income of $0.22 per share (diluted) for the third quarter and $0.61 per share (diluted) for the first nine months of 2024; Adjusted net income of $0.22 per share (diluted) for the third quarter and $0.63 per share (diluted) for the first nine months of 2024 Continued to execute on our growth strategy: Year-to-date, promoted seven advisory professionals to Managing Director and hired eight Managing Directors, including on
Moelis & Company (NYSE:MC), a leading global independent investment bank, will release its third quarter 2024 financial results after the market closes on Wednesday, October 23rd, 2024. Ken Moelis, Chairman and Chief Executive Officer, and Joe Simon, Chief Financial Officer, will also host a related conference call at 5:00pm ET on the same day (October 23, 2024) to review the financial results. Following the review, there will be a question and answer session. Investors and analysts may participate in the live conference call by dialing +1 (888) 300 4150 (domestic) or +1 (646) 970 1530 (international) and using access code 8014191. Please dial in 15 minutes before the conference call begi
Second quarter GAAP revenues of $264.6 million; Adjusted revenues of $264.6 million, up 45% from the prior year period First half GAAP revenues of $482.1 million; Adjusted revenues of $482.1 million, up 31% from the prior year period GAAP net income of $0.17 per share (diluted) for the second quarter and $0.39 per share (diluted) for the first half of 2024; Adjusted net income of $0.18 per share (diluted) for the second quarter and $0.40 per share (diluted) for the first half of 2024 Continued to execute on our growth strategy: Year-to-date, promoted seven advisory professionals to Managing Director and hired seven Managing Directors, including three Managing Director hires focu
JP Morgan analyst Kenneth Worthington maintains Moelis (NYSE:MC) with a Neutral and raises the price target from $50 to $51.
Keefe, Bruyette & Woods analyst Aidan Hall reiterates Moelis (NYSE:MC) with a Market Perform and raises the price target from $54 to $60.
Moelis (NYSE:MC) reported quarterly earnings of $0.18 per share which beat the analyst consensus estimate of $0.11 by 63.64 percent. This is a 550 percent increase over losses of $(0.04) per share from the same period last year. The company reported quarterly sales of $264.586 million which beat the analyst consensus estimate of $227.373 million by 16.37 percent. This is a 45.18 percent increase over sales of $182.243 million the same period last year.
4 - Moelis & Co (0001596967) (Issuer)
4 - Moelis & Co (0001596967) (Issuer)
4 - Moelis & Co (0001596967) (Issuer)
Moelis (NYSE:MC), a leading global independent investment bank, today announced the appointment of Dr. Louise Mirrer to its Board of Directors, effective September 17, 2024. Dr. Mirrer brings over four decades of experience in academia and the non-profit sector, including more than 20 years of executive leadership. Since 2004, she has been leading the mission and operations of the New York Historical Society as its President and CEO. Under her leadership, Dr. Mirrer has significantly enhanced the New York Historical Society's position as a leading cultural and educational institution. She oversaw the organization's $100 million capital campaign, increased the institution's annual visitorsh
Appoints Stephen Trauber as Chairman and Global Head of Energy and Clean Technology Energy bankers Muhammad Laghari and Alexander Burpee also join as Managing Directors Moelis (NYSE:MC), a leading global independent investment bank, today announced that it has appointed Stephen Trauber as Chairman and Global Head of Energy and Clean Technology. Based in Houston, Steve will lead the Firm's global efforts in this space, building on the strength of its U.S. Energy business, led by David Cunningham, and its deep expertise across the Middle East and Europe. His arrival further expands the Firm's offerings and relationships across energy services, upstream, midstream and energy infrastructure
Appoints Arash Nazhad as a Managing Director to Co-Lead the Group Together with Moelis Managing Director Rick Polhemus Moelis & Company (NYSE:MC), a leading global independent investment bank, today announced the formation of its Clean Technology Group and the appointment of Arash Nazhad as a Managing Director in Houston to co-lead the new group. The Firm's dedicated focus on energy transition and sustainability will expand Moelis's existing efforts across this dynamic global sector, including having advised on more than $50 billion of transactions globally. Arash will co-lead the group alongside current Moelis Managing Director Rick Polhemus, who has a longstanding focus on a range of
Wells Fargo initiated coverage of Moelis with a rating of Equal Weight and set a new price target of $70.00
Goldman upgraded Moelis from Sell to Neutral and set a new price target of $58.00 from $53.00 previously
Keefe Bruyette resumed coverage of Moelis with a rating of Mkt Perform and set a new price target of $56.00
SC 13G/A - Moelis & Co (0001596967) (Subject)
SC 13G/A - Moelis & Co (0001596967) (Subject)
SC 13G/A - Moelis & Co (0001596967) (Subject)
10-Q - Moelis & Co (0001596967) (Filer)
8-K - Moelis & Co (0001596967) (Filer)
8-K - Moelis & Co (0001596967) (Filer)